Interferons are natural cytokines in body. The term "interferon" defines biological activity of soluble materials that interfere with virus replication process. Interferons are expressed in response to a variety of antigens, including Viral RNA, bacterial productions and tumor proteins 1 . Generally, interferons are divided into three groups based on amino acid sequences. Group I consists of α, β, ε, δ, ω, κ interferons while the group II only has a member called interferon γ. Group III of interferons has recently been identified and included members λ1, λ2 and λ3 and play an important role in direct response to viral infections 2 . Interferons can be divided into three groups based on their cellular origin. Interferon α with the origin of Leukocyte cell (leukocyte interferon), interferon β with the origin of fibroblasts cells (fibroblast interferon) and interferon β with the origin of lymphocytes cells (immune interferon) are in this division (3 and 4) . Interferon α and β in Group I of interferon family have an important role in suppression of viral infections and inflammation 5 . Today, two completely different strategies utilize to produce different forms of recombinant interferon beta. IFNβ-Ia form general is the name of drugs produced in CHO cell lines and IFNâ-Ib is the name of drugs that produce with using of E.Coli based expression system. In times past, production of recombinant IFNβ in E. coli cells had some problems such as dimerization and oligomerization of IFNβ resultant from this method which cause isolation of betainterferon very difficult and time-consuming [4] [5] [6] [7] . In addition, it was found that produced IFNβ by microbial methods always show lower specific activity than the natural form 8 . Therefore in the biopharmaceutical industry, mammalian cell culture systems are preferred 9 . In this study, expression level of human IFNβ gene will be examined in human embryonic kidney (HEK293T) cell line transfected with the pBud. IFNβ -1a gene structure with using of protein tests such as Dot blot and Elisa.
MATERIALS AND METHODS:
Primer Design and construction of recombinant pBud.IFNâ -1a structure:
In order to evaluation of the expression level of IFNβ mRNA, pSVMdhfr vector containing human IFNâ gene was used as a template for PCR. Specific primers were designed with using of the Oligo7 software (Molecular Biology Insight, USA) in a way to allow amplification of the gene coding region of the human IFNâ from pSVMdhfr vector to be provided. In the F and R primers, sequences related to the Kpn I and Bgl II enzymes recognition sites was placed in order to cloning of IFNâ fragment in the pBud.CE4.1 expression vector. Using of GG nucleotides before KpnI restriction site in the forward primers and TC nucleotides after BglII enzyme restriction site in the reverse primer provide possibility of detecting enzyme restriction site. Design of reverse primer is in the way that stop codon TGA is removed with the aim of trace ability of produced protein with using of Anti-His Tag antibody. For this reason and follow-up to preserve of gene reading frame and expression of histidine sequence GA nucleotides placed before KpnI restriction enzyme site. One of the important factors that effect in translation is the presence of proper sequence surrounding translation start codon or the Kozak sequence, so that the amount of synthesized protein of one mRNA is related to the Kozak sequence. Changing of Kozak sequence in order to close it to constant form can help in increasing of translation level. IFNβ gene Kozak sequence in some positions is different from kozak conserve sequence. Kozak constant sequence is in "GCCRCCAUGG" form that R represents a purine base. Kozak Sequence of IFNβ gene is in "GUCAACAUGA" form. So, to close this sequence to constant Kozak sequence, two nucleotides in place -2 and -5 (according to transcription start site) must be changed to C base. Therefore, "GCCACCATGACC" nucleotide sequence related to Kozak conserved form placed in forward primer after KpnI restriction site. Designed primers were prepared by Kowsar Gene-Fanavaran-IRAN Company in lyophilized powder form. PCR reaction was done according to 95 °C Protocol for 6 minutes, followed by 35 cycles of 94 ° C for 30 seconds, 60 ° C for 30 seconds and 72 ° C for 50 seconds and a final cycle 72 ° C for 10 minutes.
The amplified fragment was purified by gel extraction kit (Thermo Scientific, USA). At the same time, pBud.CE4.1 vector was linearized with Kpn I and Bgl II enzymes. At last, amplified fragment cloned in linear vector by T4 DNA ligase enzyme. Ligation mixture was transformed to the competent E. coli.TOP10 bacteria by standard thermal shock method. The colonies containing the recombinant vector were selected on LBA plate with the final 50 µg / ml Zeocin antibiotic concentration. Recombinant colonies verified via Colony PCR method and then plasmid extraction was carried on positive colonies. RFLP analysis with KpnI and BglII enzymes and DNA sequencing with using of Bgh Rev universal primers of Fazabiotech-Iran Company were done.
Cell culture, transfection and protein extraction
After validation of recombinant construction's structure, HEK293T cells were transfected with using of Lipofectamine® LTX plus™ reagent (Invitrogen, USA) kit. 48 hours after transfection, culture medium was isolated and cells were washed with using of PBS buffer and then were detached from flask with using of 0.05 percent of trypsin. Cells were transferred to a falcon and were centrifuged with 1700 rpm for 5 minutes. After providing cell sediment, different protein extraction process was done with using of TRizol purchased from Life Technologies Company.
Protein detection
Protein was extracted from two phases of cell culture environment (in order to study the possibility of secretory protein IFNβ in the environment) and cell lysis related to transfected cells with recombinant vector, un-transfected control cells and transfected cells with null vector lacking recombinant gene with using of Trizol of Life Technologies with 15596-026 catalog number and according to company instruction. Concentration of obtained proteins were calculated with the help of Bradford standard curve. With the aim of semiquantitative analysis of protein expression, in each steps, same concentration of proteins were used.
Dot blotting technique
Dot blot is a specific method for identification and semi-quantification analysis of proteins in unknown samples. At this step, a volume equivalent to 24micrograms concentration of extracted proteins from two phases of cell culture environment and cell lysis were loaded onto nitrocellulose paper. 1% SDS protein solvent buffer as negative control and GFP-SCFV protein as positive control were used. After drying at room temperature, the membrane blocked by an appropriate volume of blocking solution (milk powder + PBS) over a night at room temperature with mild agitation on a 95 RPM shaker. Then after three times washing in cold wash buffer (PBS + Tween20) anti-His tagged antibody conjugated with HRP enzyme with proper dilution 1/1000 (4 ml antibody + 4 ml of blocking buffer) used for identification step of recombinant protein. After three washing times in PBS soluble, nitrocellulose papers were treated by this enzyme's substrate (TMB). Elisa ELISA or enzyme-linked immune sorbent assays is a biochemical method that basically is used in order to define the presence of an antibody or an antigen in studied samples. Result of ELISA is a colored reaction which is visible with eyes that has been read with using of multichannel spectrophotometer and data records and analyses, too. In this study, conjugated Monoclonal Anti-poly Histidine antibody with HRP enzyme was used to define concentration of produced IFNβ in HEK293T cell-line. After protein extraction with use of TRizol and determining hole protein concentration via Bradford method, same density equivalent of 25 micro gram in micro liter of all samples and control protein, GFP-SCFV, which has identification sequence of histidine were selected in order to loading in ELISA plate sinks. Selection of same density was for semiquantitative studies and providing completely same conditions for all samples. SDS buffer which was protein solvent in the last step of protein extraction with the use of TRizol was used as negative control. After observing color change from blue to yellow in samples in result of adding TMB, stop solutions were added and then result read by multichannel spectrophotometer, quickly.
RESULTS
pBud. IFNβ β β β β-1a structure construction PCR of IFNâ gene was performed on PSVMdhfr vector containing the gene with using of designed primers and a product with 564 bp length was amplified (Figure 1 ). After the cloning process, digestion with two KpnI and BglII enzymes was performed on recombinant vector, and exit of 564 bp IFNβ fragment, confirmed correct entrance of fragment in the pBud.CE4.1 vector (Figure 2) . pBud. IFNβ β β β β-1a transfection into HEK293T cell line Recombinant plasmid was transfected into HEK293T cell-line using Lipofectamine kit (Invitrogen, USA). Moreover, in a separate reaction, the vector without entering segment was transfected into cells. In another flask, untransfected HEK293T cells were cultured as control cells.
Protein tests
Dot blot reaction was performed to investigate the probability of producing IFNβ protein (Figure 3) . In order to final approval of IFNâ protein and performing quantitative and comparative calculations, ELISA reaction was carried out, the results are shown in Figure 4 .
DISCUSSION
Cytokines are cell active factors that are produced in a sustainable manner in response to a wide range of triggers (not only antigens). The significant feature of cytokines is the effect on cellular mechanisms and causing behavioral changes in target cells under certain circumstances (10) . Interferons were introduced as the first group of cytokines. Human IFNβ (IFN-β) is a glycoprotein that is widely produced in response to viral infections in fibroblasts cells. That is why it is called fibroblast interferon. IFNâ is used in the field of medicine, in order to treat and improve autoimmune diseases including sclerosis (MS), cell proliferation and angiogenesis inhabitation, and thereby cancer and viral infections treatments. Two analogs of IFNβ are used as drug in the treatment of MS (12) . The first type is non-glycosylated form of protein is known as IFNβ-1b which is expressed in E. coli and is currently on the market under the trade name known BetaSeron. Glycosylated form of this protein is IFNβ-1a with the trade names of Avonex and Rebif that both are expressed in ovarian cells of Chinese hamster (CHO). The efficiency of IFNβ-1b produced in bacteria is lower compared to glycosylated form, so that to achieve the efficiency in accordance with the IFNβ-1a, it is necessary to prescribe a higher dose of IFNβ-1b 13 . Continuous injection of this drug triggers the production of neutralizing and non-neutralizing antibodies against the IFNâ which inhibits the biological effects of drug and reduce its effectiveness. These factors cause lowering the treatment efficiency and side effects such as flu-like symptoms, liver damage, decreased white blood cells and platelets, depression and headache in patient 14 . To overcome these problems, other expression hosts such as yeasts, filamentous fungi, insect cells and plant cells can be used, but these hosts due to different glycosylation pattern from human are less used [15] [16] [17] . HEK293T is a derived cell line from human embryonic kidney cells that grows in cell culture and has been altered to cancer cells via transfecting with adenovirus type 5 DNA. The cells are morphologically similar to epithelial cells and are known as one of the best cell lines for the expression of recombinant proteins, and the production of viral vectors and vaccines in both transient and stable expression since 25 years ago (18, 19) . Therefore, in this study HEK293T cells have been used for the expression of recombinant interferon beta.
CONCLUSION
In this study the expression of recombinant plasmids containing IFNâ gene in HEK293T cell line were reviewed and approved with using of Dot blot and ELISA tests. All tests show successful expression of recombinant IFNβ protein in the selected cell line. This could be due to existence of eEf1a strong promoter in the selected vector and also development of conserved Kozak sequence for IFNβ protein using designed primers for gene cloning. Start speed of translation by ribosome to a large extent depends on the Kozak sequence in the vicinity of the start codon, and the produced protein amounts is dependent on the strength of the sequence 21 . In this study, by changing two nucleotide -2 and -5 in Kozak sequence and convert it to conserved form, the protein expression level shows significant increasing compared to basic expression in the cell. Briefly, in a conclusion it can be stated that IFNβ gene expression level has been increased significantly due to cloning in pBud.CE4.1 vector under strong eEf1a promoter. So the selected cell line and vector meet good conditions for producing intended pharmaceutical protein. In addition, changing Kozak sequence of IFNβ gene and convert it to stable and conserved form has significant effect on increasing gene expression level. Considering the transient expression of this protein in fibroblast cells, it is needed to produce more and more interferon protein.
